Clemente Bautista, S.; Segarra Cantón, Ó.; Padullés-Zamora, N.; García García, S.; Álvarez Beltrán, M.; Larrosa García, M.; Cabañas Poy, M.J.; Sanz-Martínez, M.T.; Vázquez, A.; Gorgas Torner, M.Q.;
et al. Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study. Pharmaceutics 2024, 16, 1577.
https://doi.org/10.3390/pharmaceutics16121577
AMA Style
Clemente Bautista S, Segarra Cantón Ó, Padullés-Zamora N, García García S, Álvarez Beltrán M, Larrosa García M, Cabañas Poy MJ, Sanz-Martínez MT, Vázquez A, Gorgas Torner MQ,
et al. Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study. Pharmaceutics. 2024; 16(12):1577.
https://doi.org/10.3390/pharmaceutics16121577
Chicago/Turabian Style
Clemente Bautista, Susana, Óscar Segarra Cantón, Núria Padullés-Zamora, Sonia García García, Marina Álvarez Beltrán, María Larrosa García, Maria Josep Cabañas Poy, Maria Teresa Sanz-Martínez, Ana Vázquez, Maria Queralt Gorgas Torner,
and et al. 2024. "Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study" Pharmaceutics 16, no. 12: 1577.
https://doi.org/10.3390/pharmaceutics16121577
APA Style
Clemente Bautista, S., Segarra Cantón, Ó., Padullés-Zamora, N., García García, S., Álvarez Beltrán, M., Larrosa García, M., Cabañas Poy, M. J., Sanz-Martínez, M. T., Vázquez, A., Gorgas Torner, M. Q., & Miarons, M.
(2024). Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study. Pharmaceutics, 16(12), 1577.
https://doi.org/10.3390/pharmaceutics16121577